股票 › BLLN
十亿分一 BLLN
美股市值排名 #2009
$113.94 +$1.55 (+1.38%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $115.26 +1.16%
开盘$112.22
昨收$112.39
当日区间$106.15 – $114.09
成交量993.3K
市值$5.44B
市盈率（TTM）118.1
股息率–
BLLN 相关新闻
匹配 BillionToOne 或代码 BLLN 的头条新闻，按最新排序。
- BillionToOne(BLLN.US) Officer Sells US$3.87 Million in Common Stock
- CCORF Initiates BillionToOne(BLLN.US) With Buy Rating, Announces Target Price $120
- Form 144 | BillionToOne(BLLN.US) Officer Proposes to Sell 3.87 Million in Common Stocks
- BillionToOne(BLLN.US) Officer Sells US$3.03 Million in Common Stock
- Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)
- William Blair Initiates BillionToOne(BLLN.US) With Buy Rating
- Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) 正面
- BTIG Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $142 正面
- J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $145 正面
- Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $125 正面
- Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH)
- Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN), ACADIA Pharmaceuticals (ACAD) and Revolution Medicines (RVMD)
- Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130 负面
- A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $100 to $145
- Stifel Nicolaus Keeps Their Buy Rating on BillionToOne, Inc. Class A (BLLN)
暂无评论——快来第一个聊聊 BLLN。
登录后参与讨论。